利用监测、流行病学和最终结果（SEER）癌症登记处进行技术评估。
Use of the SEER Cancer Registry for technology assessment.
作者信息
Klawansky S, Burdick E, Adams M, Bollini P, Orza M, Falotico-Taylor J
机构信息
Harvard School of Public Health.
出版信息
Int J Technol Assess Health Care. 1991;7(2):134-42. doi: 10.1017/s026646230000502x.
PMID:1864697
Abstract
The Surveillance, Epidemiology, and End Results (SEER) cancer registry contributed to technology assessment by providing population-based samples for detailed case-control studies, by serving as the control group in comparisons with various experimental groups, by allowing an assessment of selection bias in clinical trials, and by facilitating evaluations of classification and coding systems.
摘要
监测、流行病学和最终结果（SEER）癌症登记处通过为详细的病例对照研究提供基于人群的样本、在与各种实验组的比较中作为对照组、允许评估临床试验中的选择偏倚以及促进对分类和编码系统的评估，为技术评估做出了贡献。
Zotero 插件